z-logo
Premium
18 F‐FDG PET/MRI vs MRI in patients with recurrent adenoid cystic carcinoma
Author(s) -
Kirchner Julian,
Schaarschmidt Benedikt M.,
Sauerwein Wolfgang,
Deuschl Cornelius,
ArweilerHarbeck Diana,
Holtmann Laura,
Stebner Vanessa,
Umutlu Lale,
Antoch Gerald,
Ruhlmann Verena
Publication year - 2019
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.25485
Subject(s) - adenoid cystic carcinoma , medicine , nuclear medicine , radiology , carcinoma , pathology
Objectives To evaluate and compare the diagnostic potential of 18 F‐fluorodeoxyglucose positron emission tomography/magnetic resonance imaging ( 18 FDG‐PET/MRI) and MRI for recurrence diagnostics after primary therapy in patients with adenoid cystic carcinoma (ACC). Methods A total of 32 dedicated head and neck 18 F‐FDG PET/MRI datasets were included in this analysis. MRI and 18 F‐FDG PET/MRI datasets were analyzed in separate sessions by two readers for tumor recurrence or metastases. Results Lesion‐based sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy were 96%, 84%, 90%, 93%, and 91% for 18 F‐FDG PET/MRI and 77%, 94%, 95%, 73%, and 84% for MRI, resulting in a significantly higher diagnostic accuracy of 18 F‐FDG PET/MRI compared to MRI ( P < .005). Conclusion 18 F‐FDG PET/MRI is superior to MRI in detecting local recurrence and metastases in patients with ACC of the head and neck. Especially concerning its negative predictive value, 18 F‐FDG PET/MRI outperforms MRI.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom